Skip to Content

MYCROSOFT DYNAMIC 365 ACCOUNTING SERVICES FOR BIOTECHNOLOGY

Algebraa Business Solutions Private Limited delivers technology-led, enterprise-grade financial and operational transformation for global biotechnology organizations through Microsoft Dynamics 365 Finance, Supply Chain Management, and Governance modules. With deep expertise in standardized accounting architecture, regulated-industry compliance frameworks, and ERP-driven internal controls, Algebraa designs and operates secure, audit-ready, and regulator-aligned finance ecosystems. Its delivery model emphasizes financial integrity, statutory discipline, enterprise risk control, and centralized governance, positioning Algebraa as a long-term strategic partner for biotechnology enterprises operating across multiple countries, legal entities, and regulatory regimes.

Enterprise Financial Governance for Highly Regulated Biotech Operations ​ ​ ​

  • Centralized governance across research entities, clinical trial units, manufacturing facilities, and commercial subsidiaries
  • Multi-entity financial consolidation with disciplined intercompany eliminations
  • Embedded approval hierarchies aligned to regulated operating models
  • Continuous compliance enforcement across jurisdictions

Measured Outcomes:

  • Reduced regulatory exposure and audit observations
  • Consistent governance across global biotech operations
  • Improved confidence among regulators, investors, and boards

Audit-Ready Record-to-Report Operations with Real-Time Control ​ ​ ​ ​ ​

  • End-to-end record-to-report automation with real-time visibility
  • General Ledger, Accounts Payable, Accounts Receivable, and Cash Management governance
  • Automated reconciliations and period-end close discipline
  • Multi-ledger and multi-currency accounting across regions

Measured Outcomes:

  • Faster and more accurate month-end closures
  • Elimination of spreadsheet-driven reporting risk
  • Single source of truth for financial reporting

Cost Governance Across Research, Clinical, and Manufacturing Functions ​ ​ ​ ​

  • Advanced budgeting and forecasting for R&D, clinical trials, and production
  • Cost allocation frameworks across programs, molecules, and research pipelines
  • Margin governance across commercialized products and services
  • Scenario modeling for funding cycles and commercialization timelines

Measured Outcomes:

  • Improved cost predictability across long development cycles
  • Stronger control over research and trial expenditure
  • Executive visibility into program-level profitability

Revenue Recognition, Contract Accounting, and Statutory Alignment ​ ​ ​ ​

  • Automated revenue recognition for licensing, partnerships, and commercialization agreements
  • Contract accounting governance for long-term research collaborations
  • Embedded compliance with IFRS, GAAP, and IAS requirements
  • Transparent audit trails supporting regulatory and financial audits

Measured Outcomes:

  • Reduced revenue leakage and reporting inconsistencies
  • Statutory alignment across global biotech entities
  • Increased audit confidence and reporting accuracy

Fixed Asset and Capital Expenditure Governance ​ ​ ​

  • Full lifecycle management of laboratories, manufacturing equipment, and facilities
  • Capitalization, depreciation, impairment, revaluation, and disposal controls
  • Asset-level traceability aligned with statutory and audit requirements
  • Visibility into capital expenditure and asset utilization

Measured Outcomes:

  • Improved capital efficiency and asset accountability
  • Reduced audit findings related to asset management
  • Accurate balance sheet representation

Payroll Integration and Workforce Cost Governance ​ ​ ​ ​

  • Workforce cost control across scientists, researchers, production staff, and support teams
  • Payroll integration aligned with jurisdiction-specific statutory rules
  • Cost tracking by project, department, and legal entity
  • Automated compliance with employment-related financial obligations

Measured Outcomes:

  • Transparent workforce cost governance
  • Reduced statutory and compliance risk
  • Improved budgeting accuracy for long-term programs

Supply Chain and Procurement Governance for Banking Operations ​ ​ ​ ​

  • Controlled procurement of raw materials, lab supplies, and production inputs
  • Inventory governance for sensitive and regulated materials
  • Vendor qualification workflows and compliance checkpoints
  • Order-to-cash visibility for commercial product distribution

Measured Outcomes:

  • Reduced supply chain risk and wastage
  • Improved vendor accountability and compliance
  • Operational resilience across regulated supply chains

Internal Controls, Audit Trails, and Compliance Enforcement ​ ​ ​ ​

  • Role-based security and segregation of duties embedded within ERP workflows
  • Continuous audit trails across financial and operational transactions
  • Automated tax, VAT, and statutory reporting across USA, Canada, UK, Europe, Middle East, Africa, Australia, and New Zealand
  • Compliance enforcement aligned with global biotechnology regulations

Measured Outcomes:

  • Lower fraud and compliance risk
  • Stronger internal control maturity
  • Faster audit and regulatory response

Executive Dashboards and Board-Level Financial Intelligence ​ ​ ​ ​ ​

  • Real-time dashboards covering R&D spend, cash runway, and profitability
  • CFO-level analytics supporting funding, valuation, and regulatory reporting
  • Predictive insights for pipeline investment decisions
  • MIS reporting aligned to executive and board oversight

Measured Outcomes:

  • Faster, data-driven strategic decisions
  • Improved investor and stakeholder transparency
  • Enhanced governance confidence

Commercial, Financial, and Legal Impact ​ ​ ​ ​ ​ ​

  • Enterprise-wide discipline through standardized ERP governance
  • Real-time visibility into costs, margins, and cash flow
  • Reduced regulatory and legal exposure through embedded compliance
  • Scalable finance operations supporting partnerships, acquisitions, and global expansion

Measured Outcomes:

  • Strengthened financial resilience
  • Lower compliance and audit costs
  • Strategic readiness for growth and commercialization

Global Accounting Standards Embedded by Design

Algebraa embeds IFRS, GAAP, and IAS alignment directly into Dynamics 365 finance, asset management, payroll, and statutory reporting processes, ensuring continuous compliance without parallel systems or manual reconciliations .

Commitment to Governance-Led Biotech Transformation ​ ​ ​ ​ ​

Algebraa Business Solutions Private Limited enables biotechnology enterprises to achieve:

  • Enterprise-grade financial and operational control through Dynamics 365
  • Sustainable financial discipline across long innovation cycles
  • Reduced audit, regulatory, and compliance risk
  • Scalable, future-ready finance and supply chain operations
  • Long-term investor confidence and governance maturity

Algebraa operates as a strategic Microsoft Dynamics 365 finance and ERP partner, delivering resilient, compliant, and intelligence-driven enterprise ecosystems for the global biotechnology industry.